Sisomicin in urinary tract infection: Tolerance and efficacy study.
Twenty-one patients with gram-negative urinary tract infections were treated with sisomicin, a new aminoglycoside antibiotic. Bacteriologic cure was achieved in 62 per cent of patients, and improvement in another 33 per cent. Mild transient elevation of serum creatinine occurred in 3 patients. No other toxicity was observed. Further clinical trials with more frequent dose administration and in combination with other antibiotics is suggested.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D006801:Humans; D011552:Pseudomonas Infections / Q000188:drug therapy; D012853:Sisomicin / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D012853:Sisomicin